{
  "node_id": "us-21-cfr-part-600-biological-products-general",
  "title": "US 21 CFR Part 600: Biological Products: General",
  "domain": "Pharmaceuticals & Life Sciences",
  "version": "1.0.0",
  "last_updated": "2026-05-31",
  "bluf": "US 21 CFR Part 600 sets out general requirements for the regulation of biological products including establishment standards, inspection authority of FDA, reporting of adverse experiences and biological product deviations, and…",
  "paywall": {
    "status": "LOCKED",
    "unlock_cost_usd": "0.01",
    "skyfire_id": "41779894-ece2-4163-9761-b3b1b76e19b0"
  },
  "crosswalks": {
    "_available_keys": [
      "phsa",
      "cfr_21_601",
      "cfr_21_610",
      "cfr_21_211",
      "industry_mapping"
    ],
    "_note": "Full crosswalk values included in vault response"
  },
  "primary_citations_count": 5,
  "workflow_steps_count": 8,
  "schema_fields_count": 16,
  "citation_preview": [
    "US 21 CFR Biological Products General",
    "US 21 CFR § 600.14 Reporting of biological product deviations"
  ]
}